{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:32:31Z","timestamp":1790127151813,"version":"4.0.1"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.iac.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:25:42Z","timestamp":1783639542000},"page":"451-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Impact of Atopic Dermatitis on Quality of Life"],"prefix":"10.1016","volume":"46","author":[{"given":"William","family":"Fitzmaurice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette B.","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/j.iac.2026.04.004_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2340\/00015555924447","article-title":"Diagnostic features of atopic dermatitis","volume":"92","author":"Hanifin","year":"1980","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.iac.2026.04.004_bib2","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2012.147","article-title":"Dermatology life quality index (DLQI): a paradigm shift to patient-centered outcomes","volume":"132","author":"Finlay","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2133.1995.tb16953.x","article-title":"The children\u2019s dermatology life quality index (CDLQI): initial validation and practical use","volume":"132","author":"Lewis-Jones","year":"1995","journal-title":"Br J Dermatol"},{"issue":"12","key":"10.1016\/j.iac.2026.04.004_bib4","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamadermatol.2022.4211","article-title":"Measuring atopic eczema control and itch intensity in clinical practice: a consensus statement from the harmonising outcome measures for eczema in clinical practice (HOME-CP) initiative","volume":"158","author":"Leshem","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib5","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1365-2133.1997.d01-1225.x","article-title":"Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods","volume":"136","author":"Herd","year":"1997","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib6","first-page":"362","article-title":"Comparison of patient (POEM), observer (EASI, SASSAD, TIS) and corneometry measures of emollient effectiveness in children with eczema: findings from the COMET feasibility trial","volume":"179","author":"Ridd","year":"2018","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaad.2007.10.010","article-title":"Disease severity, scratching, and sleep quality in patients with atopic dermatitis","volume":"58","author":"Bender","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2026.04.004_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/1346-8138.12220","article-title":"Impact of disease severity on work productivity and activity impairment in Japanese patients with atopic dermatitis","volume":"40","author":"Yano","year":"2013","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/000155599750009870","article-title":"Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients","volume":"79","author":"Schmid-Ott","year":"1999","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2133.2000.03300.x","article-title":"The Nottingham Eczema Severity Score:preliminary refinement of the Rajka and Langeland grading","volume":"142","author":"Emerson","year":"2000","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/jdv.12600","article-title":"Comparison of the impairment of family quality of life assessed by disease-specific and dermatology-specific instruments in children with atopic dermatitis","volume":"29","author":"Chernyshov","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1046\/j.1365-2133.2001.03960.x","article-title":"The infants\u2019 dermatitis quality of life index","volume":"144","author":"Lewis-Jones","year":"2001","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib13","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/bjd.12563","article-title":"Infants\u2019 dermatitis quality of life index: a decade of experience of validation and clinical application","volume":"169","author":"Basra","year":"2013","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib14","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archderm.143.6.768","article-title":"Childhood atopic dermatitis impact scale: reliability, discriminative and concurrent validity, and responsiveness","volume":"143","author":"Chamlin","year":"2007","journal-title":"Arch Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.004_bib15","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jdv.16362","article-title":"Development of a validated short-form of the childhood atopic dermatitis impact scale, the CADIS-SF15","volume":"34","author":"Gabes","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib16","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1080\/000155500300012873","article-title":"Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity","volume":"80","author":"Lundberg","year":"2000","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1365-2133.2005.07050.x","article-title":"Life quality assessment among patients with atopic eczema","volume":"154","author":"Holm","year":"2006","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2340\/00015555-2797","article-title":"Psychological health status and health-related quality of life in adults with atopic dermatitis: a Nationwide cross-sectional study in South Korea","volume":"98","author":"Lee","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1085-5629(98)80026-6","article-title":"Quality of life assessments in dermatology","volume":"17","author":"Finlay","year":"1998","journal-title":"Semin Cutan Med Surg"},{"issue":"10","key":"10.1016\/j.iac.2026.04.004_bib20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1034\/j.1398-9995.2002.23708.x","article-title":"The unfavorable effects of concomitant asthma and sleeplessness due to the atopic eczema\/dermatitis syndrome (AEDS) on quality of life in subjects allergic to house-dust mites","volume":"57","author":"Terreehorst","year":"2002","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11882-001-0041-3","article-title":"Effects of allergic dermatosis on health-related quality of life","volume":"1","author":"Anderson","year":"2001","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib22","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1111\/ijd.15237","article-title":"Skindex-29 cutoffs in an atopic dermatitis sample","volume":"60","author":"Carvalho","year":"2021","journal-title":"Int J Dermatol"},{"issue":"6S","key":"10.1016\/j.iac.2026.04.004_bib23","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1097\/DER.0000000000000820","article-title":"Validity of the Skindex Mini in Patients With Atopic Dermatitis","volume":"33","author":"Dizon","year":"2022","journal-title":"Dermatitis"},{"issue":"12","key":"10.1016\/j.iac.2026.04.004_bib24","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1346-8138.2004.tb00640.x","article-title":"Measurement of the impact of atopic dermatitis on patients\u2019 quality of life: a cross-sectional and longitudinal questionnaire study using the Japanese version of Skindex-16","volume":"31","author":"Higaki","year":"2004","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2022.06.1167","article-title":"Three-question Skindex-Mini measures quality of life in children with atopic dermatitis","volume":"88","author":"Sheth","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.anai.2020.03.006","article-title":"Comparison of patient-oriented eczema measure and patient-oriented scoring atopic dermatitis vs eczema area and severity index and other measures of atopic dermatitis: a validation study","volume":"125","author":"Silverberg","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.anai.2018.07.004","article-title":"Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitis","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.004_bib28","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1111\/bjd.16543","article-title":"Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema\/dermatitis clinical trials (HOME initiative)","volume":"178","author":"Chalmers","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.004_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jid.2019.08.452","article-title":"Development, validation, and interpretation of the PROMIS itch questionnaire: a patient-reported outcome measure for the quality of life impact of itch","volume":"140","author":"Silverberg","year":"2020","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib30","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.anai.2018.07.040","article-title":"Content and construct validity, predictors, and distribution of self-reported atopic dermatitis severity in US adults","volume":"121","author":"Silverberg","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.iac.2026.04.004_bib31","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1001\/jamadermatol.2022.4211","article-title":"Harmonising Outcome Measures for Eczema (HOME) initiative. measuring atopic eczema control and itch intensity in clinical practice: a consensus statement from the harmonising outcome measures for eczema in clinical practice (HOME-CP) Initiative","volume":"158","author":"Leshem","year":"2022","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12895-019-0095-3","article-title":"Validation of the Atopic Dermatitis Control Tool (ADCT\u00a9) using a longitudinal survey of biologic-treated patients with atopic dermatitis","volume":"19","author":"Simpson","year":"2019","journal-title":"BMC Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09546634.2013.873762","article-title":"Quality of life and psychosocial issues are important outcome measures in eczema treatment","volume":"26","author":"Hon","year":"2015","journal-title":"J Dermatol Treat"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2011.01295.x","article-title":"Health-related quality of life in patients with atopic dermatitis","volume":"39","author":"Maksimovi\u0107","year":"2012","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib35","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/DER.0000000000000653","article-title":"Measurement properties of patient health questionnaire 9 and patient health questionnaire 2 in adult patients with atopic dermatitis","volume":"32","author":"Silverberg","year":"2021","journal-title":"Dermatitis : Contact, Atopic, Occupational, Drug"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1159\/000367689","article-title":"Correlation between Objective SCORAD and Three-Item Severity Score used by physicians and Objective PO-SCORAD used by parents\/patients in children with atopic dermatitis","volume":"230","author":"van Oosterhout","year":"2015","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaad.2007.06.041","article-title":"The prevalence of atopic triad in children with physician-confirmed atopic dermatitis","volume":"58","author":"Kapoor","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.iac.2026.04.004_bib38","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1080\/02770903.2020.1825732","article-title":"Quality of life in at-risk school-aged children with asthma","volume":"58","author":"Agrawal","year":"2021","journal-title":"J Asthma"},{"issue":"9","key":"10.1016\/j.iac.2026.04.004_bib39","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/children10091487","article-title":"Investigation of quality of life of patients with atopic dermatitis and quality of life, psychiatric symptomatology, and caregiver burden of their mothers","volume":"10","author":"Kilic","year":"2023","journal-title":"Children"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.25259\/IJDVL_529_19","article-title":"Quality of life in children with atopic dermatitis: A one-year prospective cohort study","volume":"88","author":"Gazibara","year":"2021","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.iac.2026.04.004_bib41","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpeds.2022.04.027","article-title":"The family impact of atopic dermatitis in the pediatric population: results from an international cross-sectional study","volume":"246","author":"Barbarot","year":"2022","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib42","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1684\/ejd.2021.4169","article-title":"Effective treatment of atopic dermatitis in small children significantly improves the quality of life of patients and their families","volume":"31","author":"Salava","year":"2021","journal-title":"Eur J Dermatol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.004_bib43","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1111\/j.1651-2227.2011.02229.x","article-title":"Quality of life in infants with atopic dermatitis and healthy infants: a follow-up from birth to 24 months","volume":"100","author":"Alanne","year":"2011","journal-title":"Acta Paediatr"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2340\/00015555-1026","article-title":"Quality of life measurement and its relationship to disease severity in children with atopic dermatitis in general practice","volume":"91","author":"van Valburg","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.iac.2026.04.004_bib45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/jdv.15496","article-title":"Validation of the dermatology-specific proxy instrument the Infants and Toddlers Dermatology Quality of Life","volume":"33","author":"Chernyshov","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.004_bib46","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/j.1742-1241.2006.01047.x","article-title":"Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema","volume":"60","author":"Lewis-Jones","year":"2006","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2133.2006.07185.x","article-title":"A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases","volume":"155","author":"Beattie","year":"2006","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib48","first-page":"281","article-title":"Quality-of-life outcomes and measurement in childhood atopic dermatitis","volume":"30","author":"Chamlin","year":"2010","journal-title":"Immunol Allergy Clin"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/pde.13727","article-title":"The impact of pediatric atopic dermatitis on families: A review","volume":"36","author":"Yang","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib50","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jaip.2022.10.032","article-title":"Patients\u2019 and Caregivers\u2019 Experiences With Atopic Dermatitis\u2013Related Burden, Medical Care, and Treatments in 8 Countries","volume":"11","author":"Capozza","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"10.1016\/j.iac.2026.04.004_bib51","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.jaip.2021.04.064","article-title":"Sleep disturbance in school-aged children with atopic dermatitis: prevalence and severity in a cross-sectional sample","volume":"9","author":"Fishbein","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1 Suppl","key":"10.1016\/j.iac.2026.04.004_bib52","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1067\/mjd.2001.117010","article-title":"Quality of life in atopic dermatitis","volume":"45","author":"Finlay","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.iac.2026.04.004_bib53","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1111\/jdv.17348","article-title":"Mapping risk factors for cumulative life course impairment in patients with chronic skin diseases - a systematic review","volume":"35","author":"von St\u00fclpnagel","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.004_bib54","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000078846","article-title":"Predicting long-term outcome in group treatment of atopic dermatitis","volume":"73","author":"Stangier","year":"2004","journal-title":"Psychother Psychosom"},{"issue":"11","key":"10.1016\/j.iac.2026.04.004_bib55","doi-asserted-by":"crossref","first-page":"e0224618","DOI":"10.1371\/journal.pone.0224618","article-title":"Does age influence the quality of life in children with atopic dermatitis?","volume":"14","author":"Ra\u017enatovi\u0107 \u0110urovi\u0107","year":"2019","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib56","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3346\/jkms.2022.37.e30","article-title":"Food Allergy and Atopic Dermatitis (FAAD) Study Group in the Korean Academy of Pediatric Allergy and Respiratory Disease. Clinical Characteristics of Atopic Dermatitis in Korean School-Aged Children and Adolescents According to Onset Age and Severity","volume":"37","author":"Jeon","year":"2022","journal-title":"J Kor Med Sci"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib57","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-2230.2008.02853.x","article-title":"Does age or gender influence quality of life in children with atopic dermatitis?","volume":"33","author":"Hon","year":"2008","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib58","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1468-3083.2006.01383.x","article-title":"Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life","volume":"20","author":"McKenna","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.iac.2026.04.004_bib59","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1590\/S0365-05962012000500008","article-title":"Quality of life in children and teenagers with atopic dermatitis","volume":"87","author":"Amaral","year":"2012","journal-title":"An Bras Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib60","doi-asserted-by":"crossref","first-page":"e044777","DOI":"10.1136\/bmjopen-2020-044777","article-title":"Young adults\u2019 perceptions of living with atopic dermatitis in relation to the concept of self-management: a qualitative study","volume":"11","author":"Lundin","year":"2021","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1525-1470.2008.00745.x","article-title":"The course of life of patients with childhood atopic dermatitis","volume":"26","author":"Brenninkmeijer","year":"2009","journal-title":"Pediatr Dermatol"},{"issue":"9537","key":"10.1016\/j.iac.2026.04.004_bib62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0140-6736(06)69283-0","volume":"368","author":"Asher","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib63","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.abd.2020.10.016","article-title":"Prevalence of atopic dermatitis in adults","volume":"97","author":"Angles","year":"2022","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.iac.2026.04.004_bib64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2147\/JAA.S317009","article-title":"Atopic dermatitis and patient perspectives: insights of bullying at school and career discrimination at work","volume":"14","author":"Stingeni","year":"2021","journal-title":"J Asthma Allergy"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib65","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-3999(03)00572-5","article-title":"The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis","volume":"57","author":"Wittkowski","year":"2004","journal-title":"J Psychosom Res"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib66","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s12325-021-01630-z","article-title":"Psychosocial comorbidities and health status among adults with moderate-to-severe atopic dermatitis: A 2017 US National Health and Wellness Survey Analysis","volume":"38","author":"Kwatra","year":"2021","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib67","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/cod.12731","article-title":"Health-related quality of life in adult dermatitis patients stratified by filaggrin genotype","volume":"76","author":"Heede","year":"2017","journal-title":"Contact Dermatitis"},{"issue":"10","key":"10.1016\/j.iac.2026.04.004_bib68","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jdv.13689","article-title":"Quality of life and disease severity in patients with atopic dermatitis","volume":"30","author":"Holm","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6S","key":"10.1016\/j.iac.2026.04.004_bib69","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1097\/DER.0000000000000908","article-title":"General and skin-specific health-related quality of life in patients with atopic dermatitis before and during the COVID-19 Pandemic","volume":"33","author":"Koszor\u00fa","year":"2022","journal-title":"Dermatitis"},{"issue":"1_suppl","key":"10.1016\/j.iac.2026.04.004_bib70","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1177\/1203475418803627","article-title":"Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document","volume":"22","author":"Gooderham","year":"2018","journal-title":"J Cutan Med Surg"},{"issue":"10","key":"10.1016\/j.iac.2026.04.004_bib71","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1080\/03007995.2023.2251883","article-title":"Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS)","volume":"39","author":"Silverberg","year":"2023","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib72","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/ced.14948","article-title":"Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis","volume":"47","author":"Schwartzman","year":"2022","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00015550410023284","article-title":"Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients","volume":"84","author":"Zachariae","year":"2004","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib74","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s13555-023-00897-0","article-title":"Factors predicting quality of life impairment in adult patients with atopic dermatitis: results from a patient survey and machine learning analysis","volume":"13","author":"Paul","year":"2023","journal-title":"Dermatol Ther"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib75","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/ijd.14763","article-title":"Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis","volume":"59","author":"Birdi","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.iac.2026.04.004_bib76","doi-asserted-by":"crossref","first-page":"adv5285","DOI":"10.2340\/actadv.v103.5285","article-title":"Impact of Atopic Dermatitis on Patients and their Partners","volume":"103","author":"Misery","year":"2023","journal-title":"Acta Derm Venereol"},{"issue":"8","key":"10.1016\/j.iac.2026.04.004_bib77","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/03007995.2022.2092352","article-title":"Impact of itch and skin pain on quality of life in adult patients with atopic dermatitis in Japan: results from a real-world, point-in-time, survey of physicians and patients","volume":"38","author":"Torisu-Itakura","year":"2022","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib78","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/bjd\/ljac058","article-title":"The association between atopic dermatitis, cognitive function and school performance in children and young adults","volume":"188","author":"Vittrup","year":"2023","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2026.04.004_bib79","doi-asserted-by":"crossref","first-page":"adv00556","DOI":"10.2340\/00015555-3918","article-title":"Impact of atopic dermatitis on work and activity impairment in Taiwan","volume":"101","author":"Chan","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1468-3083.2006.01416.x","article-title":"The handicap caused by atopic dermatitis--sick leave and job avoidance","volume":"20","author":"Holm","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib81","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/bjd.18296","article-title":"Increasing severity of atopic dermatitis is associated with a negative impact on work productivity among adults with atopic dermatitis in France, Germany, the U.K. and the U.S.A","volume":"182","author":"Andersen","year":"2020","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2017.04.019","article-title":"Impact of atopic dermatitis on health-related quality of life and productivity in adults in the United States: An analysis using the National Health and Wellness Survey","volume":"77","author":"Eckert","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.iac.2026.04.004_bib83","doi-asserted-by":"crossref","first-page":"adv00573","DOI":"10.2340\/00015555-3886","article-title":"Rapid and sustained effect of dupilumab on work productivity in patients with difficult-to-treat atopic dermatitis: results from the Dutch BioDay Registry","volume":"101","author":"Ari\u00ebns","year":"2021","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib84","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1525-1470.2005.22303.x","article-title":"The burden of atopic dermatitis: impact on the patient, family, and society","volume":"22","author":"Carroll","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2026.04.004_bib85","doi-asserted-by":"crossref","DOI":"10.1089\/derm.2023.0213","article-title":"Systematic review of steroid phobia in atopic dermatitis\u201d","author":"Fitzmaurice","year":"2024","journal-title":"Dermatitis"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/09546634.2018.1508817","article-title":"Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey","volume":"30","author":"Song","year":"2019","journal-title":"J Dermatol Treat"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib87","first-page":"3","article-title":"The impact of atopic dermatitis and corticophobia on the quality of family life","volume":"31","author":"Kotarski","year":"2023","journal-title":"Acta Dermatovenerol Croat"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib88","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1080\/09546634.2019.1657221","article-title":"TOPICOP\u00a9 scale for steroid phobia - difficulties and suggestions for application in clinical research","volume":"31","author":"Yin","year":"2020","journal-title":"J Dermatol Treat"},{"issue":"4","key":"10.1016\/j.iac.2026.04.004_bib89","first-page":"135","article-title":"Evaluation of corticophobia in patients with atopic dermatitis and psoriasis using the TOPICOP\u00a9 score","volume":"32","author":"Starbek","year":"2023","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib90","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/pde.13698","article-title":"Corticosteroid phobia (corticophobia) in parents of young children with atopic dermatitis and their health care providers","volume":"36","author":"Bos","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib91","doi-asserted-by":"crossref","first-page":"e403","DOI":"10.1016\/j.jaad.2020.03.011","article-title":"Steroid phobia isn\u2019t reduced by improving patients\u2019 knowledge of topical corticosteroids","volume":"83","author":"Feldman","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib92","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/pde.15269","article-title":"Steroid phobia on social media platforms","volume":"40","author":"Nickles","year":"2023","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib93","first-page":"581","article-title":"Steroid phobia and adherence--problems, solutions, impact on benefit\/risk profile","volume":"25","author":"Rao","year":"2005","journal-title":"Immunol Allergy Clin"},{"issue":"6","key":"10.1016\/j.iac.2026.04.004_bib94","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/00015555-2918","article-title":"The role of therapy in impairing quality of life in dermatological patients: a multinational study","volume":"98","author":"Balieva","year":"2018","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib95","first-page":"119","article-title":"Time spent on treatment (TSOT). An independent assessment of disease severity in atopic dermatitis","volume":"15","author":"Jemec","year":"2006","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib96","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pde.12698","article-title":"Quality of life in families with children with atopic dermatitis","volume":"33","author":"Pusti\u0161ek","year":"2016","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.iac.2026.04.004_bib97","doi-asserted-by":"crossref","first-page":"1066495","DOI":"10.3389\/fmed.2023.1066495","article-title":"The relationship between atopic dermatitis and atopic itch in children and the psychosocial functioning of their mothers: A cross-sectional ,study","volume":"10","author":"Kobusiewicz","year":"2023","journal-title":"Front Med"},{"issue":"5","key":"10.1016\/j.iac.2026.04.004_bib98","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5114\/ada.2023.127934","article-title":"Strategies forcoping with stress in mothers of children with atopic dermatitis - a cross-sectional study","volume":"40","author":"Kobusiewicz","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib99","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000012309","article-title":"Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament","volume":"68","author":"Pauli-Pott","year":"1999","journal-title":"Psychother Psychosom"},{"issue":"3","key":"10.1016\/j.iac.2026.04.004_bib100","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12529-022-10104-7","article-title":"Quality of life among family of patients with atopic dermatitis and psoriasis","volume":"30","author":"Snyder","year":"2023","journal-title":"Int J Behav Med"},{"issue":"1","key":"10.1016\/j.iac.2026.04.004_bib101","first-page":"29","article-title":"Impact of atopic dermatitis on the quality of life of children and their families","volume":"156","author":"Ra\u017enatovi\u0107 \u00d0urovi\u0107","year":"2021","journal-title":"Ital J Dermatol Venerol"},{"issue":"2","key":"10.1016\/j.iac.2026.04.004_bib102","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000104263","article-title":"Atopic dermatitis: impact on the quality of life of patients and their partners","volume":"215","author":"Misery","year":"2007","journal-title":"Dermatology"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856126000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:25:56Z","timestamp":1783639556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856126000329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0889856126000329"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.004","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Impact of Atopic Dermatitis on Quality of Life","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}